|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/17/22 Modular Medical, Inc. 10-Q/A 9/30/22 45:2.4M Borer Fin’l Comms, Inc. |
Document/Exhibit Description Pages Size
1: 10-Q/A Amendment to Quarterly Report HTML 433K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 20K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 20K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K
10: R1 Cover HTML 71K
11: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 99K
12: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 32K
(Parenthetical)
13: R4 Condensed Consolidated Statements of Operations HTML 62K
(Unaudited)
14: R5 Condensed Consolidated Statements of Stockholders' HTML 69K
Equity (Unaudited)
15: R6 Condensed Consolidated Statements of Cash Flows HTML 78K
(Unaudited)
16: R7 The Company and Summary of Significant Accounting HTML 54K
Policies
17: R8 Leases HTML 23K
18: R9 Ppp Note HTML 17K
19: R10 Convertible Promissory Notes HTML 25K
20: R11 Stockholders? Equity (Deficit) HTML 31K
21: R12 Stock-Based Compensation HTML 74K
22: R13 Income Taxes HTML 20K
23: R14 Commitments & Contingencies HTML 19K
24: R15 The Company and Summary of Significant Accounting HTML 87K
Policies (Policies)
25: R16 The Company and Summary of Significant Accounting HTML 23K
Policies (Tables)
26: R17 Leases (Tables) HTML 21K
27: R18 Stockholders? Equity (Deficit) (Tables) HTML 23K
28: R19 Stock-Based Compensation (Tables) HTML 75K
29: R20 The Company and Summary of Significant Accounting HTML 21K
Policies (Details)
30: R21 The Company and Summary of Significant Accounting HTML 16K
Policies (Details Narrative)
31: R22 Leases (Details) HTML 22K
32: R23 Leases (Details Narrative) HTML 17K
33: R24 Ppp Note (Details Narrative) HTML 16K
34: R25 Convertible Promissory Notes (Details Narrative) HTML 36K
35: R26 Stockholders' Equity (Deficit) (Details) HTML 28K
36: R27 Stockholders? Equity (Deficit) (Details Narrative) HTML 18K
37: R28 Stock-Based Compensation (Details) HTML 26K
38: R29 Stock-Based Compensation (Details 2) HTML 41K
39: R30 Stock-Based Compensation (Details 3) HTML 39K
40: R31 Stock-Based Compensation (Details Narrative) HTML 27K
43: XML IDEA XML File -- Filing Summary XML 75K
41: XML XBRL Instance -- modular_2qa23_htm XML 484K
42: EXCEL IDEA Workbook of Financial Reports XLSX 71K
6: EX-101.CAL XBRL Calculations -- modd-20220930_cal XML 82K
7: EX-101.DEF XBRL Definitions -- modd-20220930_def XML 144K
8: EX-101.LAB XBRL Labels -- modd-20220930_lab XML 452K
9: EX-101.PRE XBRL Presentations -- modd-20220930_pre XML 353K
5: EX-101.SCH XBRL Schema -- modd-20220930 XSD 72K
44: JSON XBRL Instance as JSON Data -- MetaLinks 180± 259K
45: ZIP XBRL Zipped Folder -- 0001019056-22-000654-xbrl Zip 120K
Exhibit 31.1
CERTIFICATION
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, James E. Besser, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q/A of Modular Medical, Inc. for the period ended September 30, 2022;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| (b) | Designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; |
| (d) | Disclosed in this report any change in the registrant’s internal controls over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| /s/ James E. Besser | Date: November 17, 2022 | |
| James E. Besser | ||
| Chief Executive Officer |
C:
| This ‘10-Q/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 11/17/22 | |||
| Filed on: | 11/16/22 | |||
| For Period end: | 9/30/22 | 10-Q, 4 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/26/22 Modular Medical, Inc. 8-K:3,5,8,9 7/21/22 12:246K Borer Fin’l Comms, Inc. |